Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
meloxicam (mobic) (1 trial)
sitagliptin (januvia) (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Osteoarthritis (Phase 3)
Trials (2 total)
Trial APIs (2 total)